Cellular processes in atherogenesis: Potential targets of Ca2+ channel blockers
- 30 June 1991
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 88 (2-3) , 109-132
- https://doi.org/10.1016/0021-9150(91)90074-d
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Regulation of the mevalonate pathwayNature, 1990
- Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interactionTrends in Pharmacological Sciences, 1990
- Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- The role of calcium in the pathogenesis of experimental arteriosclerosisTrends in Pharmacological Sciences, 1987
- Effect of elastin peptides on human monocytes: Ca2+ mobilization, stimulation of respiratory burst and enzyme secretionBiochemical and Biophysical Research Communications, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Inhibition of smooth muscle cell proliferation and endothelial permeability with flunarizine in vitro and in experimental atheromasZeitschrift für Die Gesamte Experimentelle Medizin, 1985
- Lipids and lymphocyte functionImmunology Today, 1984
- Effect of Ca2+ blocking agents on the metabolism of low density lipoproteins in human skin fibroblastsBiochemical and Biophysical Research Communications, 1982
- Direct evidence for intracellular divalent cation redistribution associated with platelet shape changeBiochemical and Biophysical Research Communications, 1976